US Patent Issued to VOYAGER THERAPEUTICS on Nov. 11 for "Redirection of tropism of AAV capsids" (Massachusetts Inventors)

ALEXANDRIA, Va., Nov. 11 -- United States Patent no. 12,467,046, issued on Nov. 11, was assigned to VOYAGER THERAPEUTICS INC. (Lexington, Mass.).

"Redirection of tropism of AAV capsids" was invented by Mathieu E. Nonnenmacher (Boston), Jinzhao Hou (Lexington, Mass.) and Wei Wang (Lexington, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure relates to compositions, methods, and processes for the preparation, use, and/or formulation of adeno-associated virus capsid proteins, wherein the capsid proteins comprise targeting peptide inserts for enhanced tropism to a target tissue."

The patent was filed on Oct. 2, 2019, under Application No. 17/282,479.

*For further information, including images...